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Abstract
Background: The effectiveness of malaria chemoprophylaxis is limited by the lack of compliance whose
determinants are not well known.
Methods: The compliance with malaria chemoprophylaxis has been estimated and analysed by validated
questionnaires administered before and after the short-term missions (about four months) in five tropical African
countries of 2,093 French soldiers from 19 military companies involved in a prospective cohort study. “Correct
compliance” was defined as “no missed doses” of daily drug intake during the entire mission and was analysed
using multiple mixed-effect logistic regression model.
Results: The averaged prevalence rate of correct compliance was 46.2%, ranging from 9.6%to 76.6% according to
the companies. Incorrect compliance was significantly associated with eveningness (p = 0.028), a medical history of
clinical malaria (p < 0.001) and a perceived mosquito attractiveness inferior or superior to the others (p < 0.007).
Correct compliance was significantly associated with the systematic use of protective measures against mosquito
bites (p < 0.001), the type of military operations (combat vs. training activities, p < 0.001) and other individual
factors (p < 0.05).
Conclusions: The identification of circumstances and profiles of persons at higher risk of lack of compliance would
pave the way to specifically targeted strategies aimed to improve compliance with malaria chemoprophylaxis and,
therefore, its effectiveness.
Background
Non-immune civilians and military personnel traveling
in malaria-endemic areas are at risk of getting malaria
and may become clinically ill during or after their travel.
Approximately 25-30 million travellers from non-tropi-
cal regions visit malaria-endemic countries annually, and
about 30,000 cases of travel-associated clinical malaria
occur each year [1]. In the UK, the incidence of
imported clinical malaria among civilian travellers visit-
ing West Africa varied from 196 cases to 52 cases/1,000
traveller-years between 2003 and 2006 [2]. In a Swedish
survey, conducted from 1997 to 2003, the annual
incidence rate of clinical malaria was 240, 302 and 357
per 100,000 travellers to East Africa, West Africa and
Central Africa, respectively [3]. In a cohort of the
French general population, followed from 1994 to 1998,
the incidence of malaria imported from endemic areas
was 435 cases per 100,000 trips, corresponding to 178
cases per 1,000 traveller-years [4]. In the French Armed
Forces, the annual incidence rate was 14 per 1,000 per-
son-years in 2006, and half of the 558 cases occurred
after the patients returned to France. Among French
soldiers serving in Côte d’Ivoire between 1998 and 2006,
the annual malaria incidence rate ranged from 27.5 to
294.7 cases per 1,000 person-years; the maximum rate
resulted from an epidemic among the troops during
fighting operations in 2002. The risk of malaria for * Correspondence: christophe.rogier@wanadoo.fr
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iods of exposure [5].
Malaria is an important threat to tourists, soldiers and
employees travelling or working in endemic areas, parti-
cularly because of the potentially rapid onset of infection
and the severity of the disease. Non-immune travellers
should be protected from malaria by chemoprophylaxis
and prophylactic measures against mosquito bites,
including insecticide-impregnated bed nets (IIBN),
repellents and insecticide-treated long-sleeved clothes
and pants. In malaria-endemic areas, the use of most of
these prophylactic measures is mandatory for non-
immune soldiers of Western armies or for non-immune
employees of most major international groups. The
resistance of Plasmodium falciparum to most anti-
malarial drugs and the resistance of Anopheles to insec-
ticides may limit the efficacy of these prophylactic mea-
sures. Chemoprophylaxis is a key component of malaria
prevention because none of the vector protection mea-
sures totally avoid mosquito bites during night activities.
However, the effectiveness of chemoprophylaxis is lim-
ited by lack of compliance with drug intake, even if the
regimen is adapted to the chemosusceptibility of P. falci-
parum [6,7].
Many clinical malaria cases and outbreaks [8-11] have
been attributed to suboptimal compliance with chemo-
prophylaxis [12,13], including among military personnel
[14-16]. In a cohort study, lack of compliance with pro-
phylactic measures was the second most important fac-
tor that determined the malaria incidence rate among
non-immune travellers [5].
It is generally acknowledged that the lack of compli-
ance with medications is unrelated to the lack of symp-
toms or risk perception. In fact, compliance
determinants are not well known, especially for chronic
diseases, such as HIV infection [17,18], diabetes [19,20],
p s y c h o s i s[ 2 1 , 2 2 ] ,t u b e r c u l o s i s[ 2 3 , 2 4 ] ,o rf o rm a l a r i a
chemoprophylaxis [25-28]. A better understanding of
the determinants of the compliance with malaria che-
moprophylaxis could pave the way for the improvement
of its effectiveness and for the development of interven-
tions aimed at enhancing compliance.
The objective of the present study was to identify the
determinants of compliance with malaria chemoprophy-
laxis among French soldiers on a short-term mission in
malaria-endemic areas of tropical Africa.
Methods
Study design and inclusion criteria
The present study was part of a larger prospective
cohort study on the risks of vector-borne diseases
among French soldiers carried out between February
2004 and September 2007. The study comprised 19
French military companies (100 to 150 individuals per
company) serving a short-term mission (about four
months) in five tropical African countries: eight compa-
nies in Côte d’Ivoire, four in Gabon, three in Chad, two
in Central African Republic and two in Senegal. The sol-
diers were required to take chemoprophylaxis and apply
protective measures against mosquitoes. These compa-
nies were selected to represent the various conditions
that French soldiers experience in Africa. All members
of the companies designated for the mission were eligi-
ble for the study and were invited to participate. Soldiers
absent from the regiment on the dates of the surveys or
who left the company between the survey and the
departure or during the mission were excluded from the
analysis.
The protocol was approved by the ethical committee
Marseille II (Advice no. 02/81, 12/13/2002). The
informed consent of each participant was obtained at
the beginning of the study after a thorough explanation
of its purpose.
Two self-administered questionnaires containing beha-
vioural items were filled out by each soldier and vali-
dated by a member of the research team. The first
survey was administered no earlier than 15 days before
their departure, and the second was completed no later
than 15 days after their return.
Data collection
The dependant variable was the level of compliance with
malaria chemoprophylaxis during the mission as
assessed retrospectively by the return questionnaire.
“Correct” compliance was defined as “No missed doses”
of daily drug intake during the entire mission, while
“incorrect” compliance was defined as one of the three
other possible responses: “Less than one missed dose
per month,”“ One or more missed doses per month, but
less than one missed dose per week” or “One or more
missed doses per week”.
Independent variables that were considered potential
determinants of compliance were recorded for each sol-
dier either upon departure or return. These variables
were related to individual characteristics or to the parti-
cular settings of the mission, as described below.
Variables relative to the mission were the dates of
departure and return, country and mission type, such
asmilitary operation or training. Demographic and beha-
vioural variables were age, gender, rank, usual morning-
ness and eveningness (as determined using the reduced
Horne and Östberg morningness-eveningness question-
naire [29-31]), wake and sleep times during the mission,
previous travel overseas or other malaria-endemic areas
and tobacco consumption. Morningness and evening-
ness were used to determine the chronotype, i.e. the cir-
cadian rhythm of the soldiers: morning people waking
up early and being more alerti nt h ef i r s tp a r to ft h e
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hours and preferring to go to bed late.
Other variables pertained to the occurrence of impor-
tant familial events during the mission (e.g.,b i r t ho fa
child, illness or death of a relative or friend, or separa-
tion or announcement of a divorce). Other variables
included the subjective perceived risk level during the
mission associated with i) a dangerous situation, ii) the
individual likelihood of acquiring clinical malaria, and
iii) the severity of disease if malaria were contracted.
Variables related to protective measures against vec-
tors included the condition of the received IIBN and the
use of each protective measure designated for each type
of activity during the mission (guard, operation out of
the military camp, free time, and time in the military
camp). A global score was calculated by combining the
frequency of use of each antivectorial measure during
each activity with the time spent in each activity. More-
over, a global variable summarizing the use of all anti-
vectorial protective measures (including repellents, long
sleeved clothes and IIBN) was constructed.
Independent variables relative to the chemoprophy-
laxis were the drug itself (either doxycycline or chloro-
quine-proguanil combination with once-daily dosages),
tolerance and usual time schedules of intake.
The variables incorporating medical antecedents were
allergy to insect bites, usual cutaneous response to mos-
quito bites and medical history of malaria, leishmaniasis
or dengue fever (i.e., themain vector-borne diseases
experienced by the French Forces). Variables pertaining
to medical events that occurred during the mission
included clinical malaria, non-malarial fever, diarrhoea,
boil, other severe infectious disease (i.e., medical issues
that required hospitalization or drug treatment for one
month or more), perceived frequency of mosquito bites
and perceived personal mosquito attractiveness.
Statistical methods
Data were recorded using EpiDATA v3.0 and were
checked for consistency before statistical analysis using
STATA 9.0 (StataCorpLP, College Station, TX, USA).
Only participants who completed both questionnaires
were considered for statistical analysis. Missing values
affected less than 1% of the participants and were
replaced using the single imputation method. When a
question was not asked to one or more companies, the
responses were coded as missing data for those
companies.
The confidence interval of correct compliance with
malaria chemoprophylaxis was estimated by taking into
account the clustered design of the study using the svy
commands under STATA 9.0. Compliance with chemo-
prophylaxis was analysed as a dependant variable
according to individual and company characteristics
using a random effect mixed logistic regression model.
The model was designed to take into account the intra-
company correlations that could exist due to the sam-
pling design (company effect as random effect). The
logistic model was also adjusted using a generalized esti-
mating equations (GEE) approach. Random effect and
GEE regression models allow the estimation of com-
pany-specific and population-averaged effects, respec-
tively [32].
First, a descriptive analysis of the independent vari-
ables was performed. A bivariate analysis was then con-
ducted by entering each independent variable in a
logistic regression model. Variables were retained for
the multivariate analysis when their effect had a p-value
less than 0.25 [33]. A backward stepwise selection pro-
cedure was applied to retain the significant (p < 0.05)
independent variables and their interactions in the final
model. The statistical quality of the final model was
assessed by looking at the adequacy between observed
and predicted probabilities of correct compliance.
Results
Study population
Of 2,901 eligible soldiers from 19 companies, 808 were
excluded because they did not complete both question-
naires, leaving a sample of 2,093 subjects. The most
common reason for not completing the questionnaires
was the absence of the subject from the regiment at the
time of the survey (because of holidays, training or a
mission). Some soldiers who had planned to deploy to
Africa and completed the first questionnaire did not tra-
vel and were replaced by others who had not completed
the survey. Some soldiers returned to France before the
rest of their company or were transferred to another
regiment and were not present at the time of the second
survey. The rate of refusal to participate in the study
was lower than 5%.
The descriptive characteristics of the companies are
summarized in Table 1. A total of 17 clinical malaria
cases occurred during the mission among the 2,093 sol-
diers, which corresponds to an incidence rate of 0.81
c a s e sp e r1 0 0s o l d i e r - m i s s i o n s( 2 . 3 7c a s e sp e r1 0 0s o l -
dier-years).
Compliance with the chemoprophylaxis
Assessment of compliance level with chemoprophylaxis
was based on the self-reported occurrences of daily
medication doses missed during the mission. “No
missed doses” was indicated by 967 out of 2,093 sol-
diers, or 46.2% “correct” compliance. Between compa-
nies, the lowest proportion of correct compliance was
9.6%, and the highest was 76.6%.
Among the other three responses corresponding to
incorrect compliance, “less than one missed dose per
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more missed doses per month but less than one missed
dose per week” was declared by 298 soldiers (14.2%);
and “o n eo rm o r em i s s e dd o s e sp e rw e e k ” was declared
by 191 soldiers (9.1%).
The frequency of correct compliance was calculated
according tothe following: variables related to the mis-
sion, demographics and behavioral characteristics; the
occurrence of particular events during the mission and
the perception of risks; use of anti-mosquito protective
measures; use of malaria chemoprophylaxis; and medical
history and occurrence of medical events during the
mission. These data are shown in Tables 2, 3, 4, 5 and
6, respectively.
The variables retained in the final mixed multivariate
logistic regression model are shown in Table 7. Correct
compliance was significantly associated with the sys-
tematic use of one or more protective measures against
mosquito bites, the perception of clinical malaria as
potentially not severe or very severe (versus moderately
severe), the birth of a child and the type of military
operations (combat or training activities). Incorrect
compliance was significantly associated with evening-
ness, a medical history of clinical malaria and a
Table 1 Characteristics of the companies
Comp Country of the
mission
Mission
dates
(MM/YY)
Type of the
mission
Nb of
soldiers
Nb of
men
Age: median (25%-
75% quantile)
Nb of soldiers with
correct compliance
Nb of clinical
malaria attacks
Start End
1 Ivory Coast 02/
04
06/
04
Operation 144 143 26 (25 - 29) 51 (35.4%) 3
2 CAR 02/
05
05/
05
Operation 115 115 26 (23 - 29) 53 (46.1%) 2
3 Ivory Coast 02/
05
05/
05
Operation 108 108 22 (21 - 26) 70 (64.8%) 1
4 Ivory Coast 02/
05
05/
05
Operation 95 95 22 (20 - 24) 55 (57.9%) 0
5 Ivory Coast 02/
05
05/
05
Operation 73 72 23 (22 - 26) 38 (52.1%) 1
6 Senegal 06/
05
09/
05
Training 133 132 26 (22 - 30) 16 (12%) 0
7 Ivory Coast 06/
08
09/
05
Operation 84 84 25 (22 - 28.5) 54 (64.3%) 0
8 Ivory Coast 06/
08
09/
05
Operation 72 66 24 (22.5 - 28.5) 44 (61.1%) 1
9 Chad 10/
05
01/
06
Operation 134 130 24 (21 - 27) 85 (63.4%) 2
10 Senegal 02/
06
05/
06
Training 102 100 25 (22 - 28) 16 (15.7%) 0
11 Chad 02/
06
05/
06
Operation 83 78 25 (22 - 29) 44 (53.0%) 1
12 Gabon 07/
06
11/
06
Training 94 94 23.5 (21- 29) 9 (9.6%) 1
13 Gabon 07/
06
11/
06
Training 114 114 24 (21 - 29) 12 (10.5%) 2
14 Chad 06/
06
09/
06
Operation 189 185 24 (21 - 29) 130 (68.8%) 0
15 Gabon 12/
06
04/
07
Training 125 123 25 (22 - 30) 49 (39.2%) 0
16 Gabon 12/
06
04/
07
Training 135 133 24 (22 - 31) 38 (28.1%) 1
17 CAR 06/
07
09/
07
Operation 102 102 23 (20 - 29) 78 (76.5%) 0
18 Ivory Coast 06/
07
09/
07
Operation 94 92 22 (20 - 25) 72 (76.6%) 1
19 Ivory Coast 06/
07
09/
07
Operation 97 96 23 (21 - 28) 53 (54.6%) 1
Total 02/04 09/
07
2093 2062 24 (21 -
28)
967
(46.2%)
17
Comp: Company; Nb: Number; CAR: Central African Republic
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the other soldiers. Compliance was not significantly
associated with gender, age, rank or previous travels in
malaria-endemic areas. The occurrence of clinical
malaria during the mission was significantly associated
with a lack of compliance as measured by the question-
naire (OR = 5.7, 95% CI: 1.6-20.2, p = 0.0074).
There was no significant interaction between indepen-
dent variables. The company effect was significant in the
final model. The OR estimates were similar for both the
random effect and GEE regression models.
Discussion
Many studies have been conducted in order to identify
factors that influence compliance with medications,
most of which focused on treatments to cure, reduce or
delay complications and symptoms caused by chronic
diseases. Only a few studies have assessed compliance in
the context of chemoprophylaxis. Recently, the concept
of adherence has supplanted compliance, as adherence
implies that the patient agrees with the prescribed
recommendations rather than passively obeying them
(World Health Organization, 2003) [34]. However, in
the present study, the concept of compliance was more
suitable in the particular context of mandatory prophy-
lactic measures. This work identified both collective and
individual determinants of correct compliance with
malaria chemoprophylaxis among French soldiers ser-
ving a short-term mission in intertropical Africa.
Individual factors
The systematic use of protective measures against mos-
quito bites (including long-sleeved clothes and pants,
repellents and bed net) was associated with correct com-
pliance with chemoprophylaxis. Whereas previous stu-
dies showed no association [28] or even a competition
[35] between the use of prophylactic measures, the pre-
sent study showed that those who stated compliance
Table 2 Variables related to the mission as well as the demographics and behavioral characteristics
N N-CC Prevalence of CC
% (95% CI) OR 95% CI p value
Type of the mission < 0.001
Training 703 140 19.9 (10.0 - 29.8) 1
Military operation 1390 827 59.5 (51.8 - 67.2) 6.17 3.36 - 11.32
Duration of the mission (mo) 0.81 0.61 - 1.07 0.1313
Age 0.2150
18 - 24 y. 1071 503 47.0 (34.9 - 59.1) 1
25 y. and more 1022 464 45.4 (34.115 - 56.4) 1.11 0.94 - 1.30
Gender 0.3667
Men 2062 953 46.2 (34.8 - 57.6) 1
Women 31 14 45.2 (29.6 - 60.7) 0.74 0.38 - 1.4
Rank 0.0329
JRs - NCOs 1610 728 45.2 (33.9 - 56.6) 1
Os - WOs 483 239 49.5 (37.7 - 61.3) 1.22 1.02 - 1.47
Favorite time for activities 0.0097
Morning type 531 252 47.5 (35.0 - 59.9) 1
Intermediate type 1248 585 46.9 (35.3 - 58.5) 0.83 0.69 - 1.00
Evening type 314 130 41.4 (30.1 - 52.7) 0.68 0.52 - 0.87
Bedtime during the mission 0.0033
Before or at midnight 1607 778 48.4 (35.7 - 61.1) 1
After midnight 342 138 40.4 (30.0 - 50.7) 0.69 0.55 - 0.86
NA (Company 1) 144 51 35.4 (27.5 - 43.3) 0.57 0.09 - 3.56
Previous overseas travel 0.1778
No 435 244 56.1 (44.7 - 67.5) 1
Yes 1658 723 43.6 (32.3 - 54.9) 0.87 0.72 - 1.06
Tobacco consumption 0.0420
Nonsmoker 934 451 48.3 (36.2 - 60.4) 1
Smoker 1-20 cig/d. 903 406 45.0 (33.0 - 56.9) 0.86 0.73 - 1.02
Smoker >20 cig/d. 256 110 43.0 (32.3 - 53.7) 0.75 0.58- 0.96
N: Number of subjects; CC: Subjects with correct compliance; NA: Not Available
JRs - NCOs: junior ranks and noncommissioned officers; Os - WOs: officers and warrant officers; Cig/d.: cigarettes per day.
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mosquito measures, suggesting common determinants of
these prophylactic behaviors.
Among life events, only the birth of a child during the
mission was associated with correct compliance. This
could be explained by an increase in the level of respon-
sibility felt towards the newborn, a greater maturity
among those in a position to father a child or internal
pressure from the family [23,36], any of which could
lead to a better awareness of the danger of malaria.
The “morning-type” soldiers, as determined by both
the reduced Horne and Östberg morningness-evening-
ness questionnaire and by sleep/wake hours during the
mission, were more likely to have correct compliance.
Similarly, “evening-type” soldiers were less compliant
with chemoprophylaxis. Eveningness has been asso-
ciated with certain personality traits and dimensions
(such as novelty-seeking, impulsivity, independent
behaviour, risk taking, anti-conformism, lack of persis-
tence and extraversion) [37-39] and is linked to both
genetic factors [40] and environment [41].
Furthermore, morning-types are known to have a heal-
thier lifestyle [42,43]. Thus, eveningness appears to be
a risk factor for lack of compliance with malaria che-
moprophylaxis, and it could be considered a target for
focused interventions.
It has been shown that travellers who perceived them-
selves at high risk of becoming ill with malaria after
returning home [26] or travellers to high-risk malaria-
endemic areas who had correct risk perceptions [28]
were more often compliant with chemoprophylaxis. The
present study showed that subjects who either had a
high or a low perception of the potential severity of clin-
ical malaria were more often compliant compared to
those who perceived it as mildly severe. This unexpected
significant association persisted after adjusting for the
other covariates and was explained by no interaction.
The high level of compliance among those having a
“very severe” perception confirmed the previous results.
On the other hand, the “not severe” perception could be
a consequence of feeling protected by one’s correct
compliance with an effective prophylactic measure.
Table 3 Variables related to the occurrence of events during the mission and the perception of risks
N N-CC Prevalence of CC
% (95% CI) OR 95% CI p value
Birth of a child 0.1168
No 2040 941 46.1 (35.0 - 57.3) 1
Yes 53 26 49.1 (29.4 - 68.7) 1.49 0.91 - 2.46
Death of a relative or a friend 0.5877
No 2004 928 46.3 (35.1 - 57.5) 1
Yes 89 39 43.8 (27.1 - 60.6) 1.11 0.76 - 1.63
Disease of a relative or a friend 0.9812
No 1996 926 46.4 (35.0 - 57.8) 1
Yes 97 41 42.3 (30.3 - 54.2) 1 0.69 - 1.44
Announcement of a separation or a divorce 0.2850
No 2048 943 46.0 (34.7 - 57.4) 1
Yes 45 24 53.3 (32.4 - 74.3) 1.34 0.78 - 2.29
Perception of a dangerous situation 0.2358
No 2041 947 46.4 (35.0 - 57.8) 1
Yes 52 20 38.5 (23.8 - 53.1) 0.73 0.44 - 1.23
Perception of personal malaria risk compared to other soldiers 0.4728
Inferior 280 132 47.1 (34.3 - 60.0) 1
Equivalent 1388 644 46.4 (34.3 - 58.5) 1.04 0.82 - 1.32
Superior 425 191 45.0 (33.1 - 56.8) 0.92 0.70 - 1.21
Perception of the severity of malaria 0.0295
Not severe 254 136 53.5 (42.7 - 64.4) 1.3 1.02 - 1.66
Mildly severe 1473 654 44.4 (32.4 - 56.4) 1
Very severe 366 177 48.4 (35.1 - 61.6) 1.22 0.99 - 1.51
Perceived mosquito attractiveness compared to other soldiers 0.0024
Inferior to the others 608 275 45.2 (32.1 - 58.3) 0.77 0.64 - 0.93
Equivalent to the others 998 490 49.1 (38.3 - 59.9) 1
Superior to the others 487 202 41.5 (29.0 - 53.9) 0.75 0.61 - 0.91
N: Number of subjects; CC: Subjects with correct compliance
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together in behavioral studies [44].
Similarly, individuals who perceived themselves to be
either more or less potent mosquito attractors than others
were more compliant with chemoprophylaxis. This unex-
pected significant association also persisted after adjusting
for the other covariates. Individuals who considered them-
selves less attractive to mosquitoes could be less compliant
because of the perception of a lower risk of contracting
malaria. In contrast, those who thought that they attracted
mosquitoes more so than others were expected to be
more compliant with anti-mosquito measures and could
have believed that these anti-vectorial measures were suffi-
cient to protect them. However, no significant interaction
was found between the effects of the perceived mosquito
attractiveness and compliance with anti-mosquito mea-
sures or chemoprophylaxis. Other determinants induced
by the military setting such as fatalism or coping with dan-
ger by avoidance, denial or vulnerability could explain this
unexpected association.
Table 4 Variables related to adherence to anti-mosquito protective measures
N N-CC Prevalence of CC
% (95% CI) OR 95% CI p value
Condition of the received bed net 0.0502
Bad condition 736 338 45.9 (32.3 - 59.5) 1
Good condition 1145 543 47.4 (36.0 - 58.9) 1.19 1.00 - 1.42
NA: Company 1 or no net received 212 86 40.6 (25.9 - 55.2) - -
Use of repellents before bedtime 0.0144
Not always 2019 919 45.5 (34.4 - 56.6) 1
Always 74 48 64.9 (45.0 - 84.8) 1.73 1.11 - 2.67
Use of insecticides for clothes before bedtime 0.0592
Not always 1922 894 46.5 (34.5 - 58.5) 1
Always 27 22 81.5 (71.4 - 91.6) 2.46 1.15 - 5.28
NA (Company 1) 144 51 35.4 (27.5 - 43.3) 0.62 0.10 - 3.80
Long clothes worn before bedtime 0.0026
Not always 1025 384 37.5 (22.7 - 52.2) 1
Always 1068 583 54.6 (46.4 - 62.8) 1.33 1.11 - 1.61
Use of a bed net during sleep < 0.0001
Not always 981 411 41.9 (26.1 - 57.7) 1
Always 1112 566 50.0 (37.9 - 62.1) 1.57 1.28 - 1.94
Systematic use of protective measures: long clothes, repellents, and bed net < 0.0001
No one 653 249 38.1 (21.4 - 54.9) 1
One of them 671 277 41.3 (26.8 - 55.8) 1.31 1.05 - 1.63
Two or three of them 769 441 57.4 (48.0 - 66.7) 2.03 1.56 - 2.65
N: Number of subjects; CC: Subjects with correct compliance; NA: Not Available
Table 5 Variables related to the chemoprophylaxis
N N-CC Prevalence of CC
% (95% CI) OR 95% CI p value
Drug prescribed 0.0592
Chloroquine - proguanil 409 259 63.3 (55.3 - 71.4) 1
Doxycycline 1675 701 41.9 (29.9 - 53.8) 0.65 0.34 - 1.26
Mefloquine or other 9 7 77. 8 (46.9 - 100.0) 2.9 0.58 - 14.44
Tolerance to the intake 0.1077
Rather bad to very bad 173 64 37.0 (18.4 - 55.6) 1
Rather good 1010 442 43.8 (32.7 - 54.9) 1 0.74 - 1.35
Very good 910 461 50.7 (39.7 - 61.7) 1.19 0.88 - 1.61
Regularity of the day time of the intake 0.0419
Rather at the same time 1622 826 50.9 (40.1 - 61.8) 1
Rather at different times 327 90 27.5 (14.9 - 40.2) 0.75 0.59 - 0.94
NA (Company 1) 144 51 35.4 (27.5 - 43.3) 0.58 0.10 - 3.44
N: Number of subjects; CC: Subjects with correct compliance; NA: Not Available
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with present lack of compliance. This suggests that hav-
ing experienced an episode of clinical malaria was not a
factor contributing by itself to the adoption of prophy-
lactic behaviours [26]. Therefore, other arguments than
the risk of contracting malaria should be used to con-
vince these individuals to reach an optimal compliance
with chemoprophylaxis.
The present study did not show any significant asso-
ciation between compliance and gender or age, although
it has previously been shown that women and older tra-
vellers were more compliant [26,35,45]. However, the
present work was conducted among French soldiers,
where the proportion of women and older persons was
small, leading to a lack of power to show such
associations.
Collective factors
Military operation-type missions were associated with
correct compliance, independent of the country or the
army corps. In such conditions, the soldiers were prob-
ably more closely supervised by the command, so they
were submitted to a higher pressure to comply with the
chemoprophylaxis. Indeed, the good health of the sol-
diers, including the prevention of malaria, was an impor-
tant concern of the command because of the operational
nature of the mission: the global health of the group had
to be preserved for a military purpose [46]. Compliance
with malaria chemoprophylaxis was also better among
civilian travellers who were taking part in an organized
trip compared to those traveling independently [35].
After taking all these factors into account, there was
still a significant group effect; that is, significant
behaviour determinants associated with the companies
that were not identified in the present study. More-
over, the rate of compliance was very heterogeneous
among companies, meaning probably that individual
behaviours were not independent within a company.
This unconscious or conscious imitation was not
explained by the previous determinants. The lack of
isolated soldier limited the possibility of studying the
group effect. Compliance with anti-malarial prevention
measures appears to be the end result of a complex
mixing of the perception of risks and of protective/
curative interventions, the acceptance of these mea-
sures and their application in spite of discomfort; qua-
litative approaches could be appropriate for exploring
these complexities [47].
In this study, the compliance was measured based on
a self-administered questionnaire. This method could
overestimate the rate of correct compliance, as pre-
viously shown for anti-viral therapy [48] or malaria
chemoprophylaxis [45]. A preliminary study with an
electronic device (MEMS®: Medication Event Monitor-
ing System) that records the date and time of bottle
cap opening has been conducted to objectively assess
the rates of compliance in the first company. This
electronic monitoring is considered to be more accu-
rate than questionnaires, diaries or counts of returned
untaken tablets for the assessment of compliance
[49,50]. If correct compliance is defined as 90% or
more of daily prophylactic drug intake completed
(using the MEMS® as the reference), the answers to the
questionnaire used in the present study had a 0.69 and
0.75 sensitivity and specificity, respectively, to the
assessment of the correct compliance. These quality
Table 6 Variables related to the medical history of infectious diseases or the occurrence of diseases during the
mission
N N-CC Prevalence of CC
% (95% CI) OR 95% CI p value
Medical history of malaria 0.0002
No 1870 902 48.2 (37.0 - 59.5) 1
Yes 180 50 27.8 (17.2 - 38.4) 0.59 0.44 - 0.79
Does not know 43 15 34.9 (18.6 - 51.1) 0.51 0.28 - 0.91
Medical history of dengue fever 0.0625
No 1961 921 46.97 (35.7 - 58.3) 1
Yes 83 26 31.32 (19.3 - 43.3) 0.66 0.44 - 1.00
Does not know 49 20 40.82 (22.0 - 59.7) 0.69 0.40 - 1.16
Occurrence of a disease during the mission 0.1223
No 1177 540 45.9 (34.2 - 57.6) 1
Yes 916 427 46.6 (34.5 - 58.8) 0.88 0.74 - 1.04
Occurrence of clinical malaria during the mission 0.0074
No 2076 965 46.5 (35.2 - 57.8) 1
Yes 17 2 11.8 (3.6 - 27.1) 0.18 0.05 - 0.63
N: Number of subjects; CC: Subjects with correct compliance
Resseguier et al. Malaria Journal 2010, 9:41
http://www.malariajournal.com/content/9/1/41
Page 8 of 11indexes were close to those previously found by others
using only one question [49,51,52]. The questionnaire
used in the present study was then considered appro-
priate for investigation of compliance. Indeed, the
occurrence of clinical malaria during the mission was
strongly associated with compliance as estimated by
the questionnaire.
T h er e s u l t so ft h ep r e s e n ts t u d ya r ea p p l i c a b l et o
French soldiers travelling for a short-term mission in
intertropical Africa because the companies were repre-
sentative of the different malaria-endemic areas to
which they could be sent. The prevalence of correct
compliance with malaria chemoprophylaxis among sol-
diers was close to those reported elsewhere among
civilian travellers [4,28,35], and several determinants of
compliance were similar to those identified among
civilian travellers as well. Even if all the results of the
present study could not be directly extrapolated to
civilian travellers, they are useful for identifying key
factors to improve compliance with malaria chemopro-
phylaxis. Indeed, the present study conducted on a
large sample of travellers has shown collective and
individual factors, including a priori determinants like-
eveningness, which are associated with compliance.
The identification of circumstances and profiles of per-
sons at higher risk of lack of compliance would allow
the implementation of specifically targeted strategies of
health information, education, and communication, in
order to improve compliance with malaria chemopro-
phylaxis and therefore its effectiveness.
Table 7 Multivariate logistic regression analysis
N N-CC RE
aOR IC 95% p-value
Type of the mission < 0.0001
Training 703 140 1.00
Military operation 1390 827 6.46 3.92 - 10.65
Preferred time for activities 0.0805
Morning type 531 252 1.00
Intermediate type 1248 585 0.83 0.65 - 1.05
Evening type 314 530 0.69 0.50 - 0.96
Bedtime during the mission < 0.0001
Before or at midnight 1607 778 1.00
After midnight 342 138 0.73 0.56 - 0.96
Not Available (Company 1) 144 51 0.30 0.17 - 0.52
Birth of a child 0.0421
No 2040 941 1.00
Yes 53 26 1.99 1.02 - 3.88
Perception of the severity of malaria 0.0171
Not severe 254 136 1.44 1.06 - 1.96
Mildly severe 1473 654 1.00
Very severe 366 177 1.31 1.00 - 1.71
Systematic use of protective measures: long clothes, repellents, and bed net 0.0001
No one 653 249 1.00
One of them 671 277 1.39 1.03 - 1.87
Two or three of them 769 441 2.12 1.49 - 3.01
Medical history of clinical malaria < 0.0001
No 1870 902 1.00
Yes 180 50 0.45 0.30 - 0.66
Does not know 43 15 0.44 0.22 - 0.87
Perceived mosquito attractiveness, compared to other soldiers 0.0029
Inferior to the others 608 275 0.71 0.56 - 0.89
Equivalent to the others 998 490 1.00
Superior to the others 487 202 0.71 0.55 - 0.91
Random effect (i.e. company effect) < 0.0001
N: Number of subjects; CC: Subjects with correct compliance; NA: Not Available
aOR: adjusted OR; RE: Random Effect Model
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